ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer
December 18, 2019The IMbrave150 study combination immunotherapy, with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab, has proven positive results by enhancing the potential of the immune system to combat Hepatocellular Carcinoma (HCC) among Asian pati
Pharma Sources Insight January 2025
